JPL Wealth Management »

Atrium Therapeutics shares owned by JPL Wealth Management

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by JPL Wealth Management from 13F filings

Historical chart of JPL Wealth Management investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by JPL Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by JPL Wealth Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $81 6 13.50

More positions owned by JPL Wealth Management

Spdr Series Trust St Str P500etf (SPYM)
UnitedHealth (UNH)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Schwab Strategic Tr Sht Tm Us Tres (SCHO)
Broadcom (AVGO)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Ea Series Trust Alpha Architect (CAOS)
Caterpillar (CAT)
Ea Series Trust Alpha Architect (AAEQ)
Invesco Exch Traded Fd Tr Ii S&p 500 Momntm (SPMO)
Vanguard Index Fds Total Stk Mkt (VTI)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Ea Series Trust Us Quan Momentum (QMOM)
Ishares Tr Ishares Semicdtr (SOXX)

View all positions for JPL Wealth Management

Top funds holding Atrium Therapeutics

Sessa Capital IM
BlackRock
Susquehanna International
Vanguard Capital Management
CRCM
TIG Advisors
Geode Capital Management
Two Sigma Investments
Goldman Sachs Group
683 Capital Management
Fort Hoosac Management
Cantor Fitzgerald, L. P.
Slotnik Capital
Weiss Asset Management LP[1
Millennium Management

View all funds holding Atrium Therapeutics